(Q48856290)

16 February 2018

reason for preferred rank

title

Clinical strategies for evaluating ect mechanisms — pharmacological, biochemical and psychophysiological approaches (English)

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

12 August 2023

Clinical strategies for evaluating ECT mechanisms--pharmacological, biochemical and psychophysiological approaches (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6137030

12 August 2023

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

12 August 2023

author name string

B. Lerer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6137030

12 August 2023

N. Sitaram

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6137030

12 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6137030

12 August 2023

publication date

1 January 1983

1 reference

16 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0278584683901203?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

https://api.elsevier.com/content/article/PII:0278584683901203?httpAccept=text/plain

12 August 2023

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Progress in Neuro-Psychopharmacology & Biological Psychiatry

12 August 2023

published in

1 reference

16 February 2018

volume

7

1 reference

16 February 2018

issue

2-3

1 reference

16 February 2018

page(s)

309-333

1 reference

16 February 2018

Antidepressants and dopamine autoreceptors: implications for both a novel means of treating depression and understanding bipolar illness

cites work

4

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Lack of effect of repeated electroconvulsive shock on [3H]spiroperidol and [2H]5-hydroxytryptamine binding and cholinergic parameters in rat brain.

12 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Effects of electroconvulsive treatment on growth hormone secretion induced by monoamine receptor agonists in reserpine-pretreated rats

12 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Neuroendocrine evidence for increased responsiveness of dopamine receptors in humans following electroconvulsive therapy.

12 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Repeated electroconvulsive shock (ECS) and morphine tolerance: demonstration of cross-sensitivity in the rat

12 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

The effect of electroconvulsive shock at a clinically equivalent schedule on rat cortical beta-adrenoceptors.

12 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Effect of electroconvulsive shock on monoaminergic receptor binding sites in rat brain

12 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Influence of amphetamines on plasma corticosteroid and growth hormone levels in man.

12 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Adrenergic receptor control mechanism for growth hormone secretion

12 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients

12 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Acute psychologic and neuroendocrine effects of dextroamphetamine and methylphenidate

12 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility

12 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Neuroendocrine and amine studies in affective illness

12 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Presynaptic adrenergic receptor sensitivity in depression. The effect of long-term desipramine treatment

12 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Assessment of α2 adrenergic autoreceptor function in humans: Effects of oral yohimbine

12 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Hormone Responses to Methylamphetamine in Depression: a New Approach to the Noradrenaline Depletion Hypothesis

12 August 2023

21

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Growth hormone and other responses to clonidine in patients with endogenous depression

12 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Electroconvulsive shock: progressive dopamine autoreceptor subsensitivity independent of repeated treatment

12 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Repeated tricyclics induce a progressive dopamine autoreceptor subsensitivity independent of daily drug treatment

12 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Effect of ECT on the neuroendocrine response to apomorphine in severely depressed patients

12 August 2023

26

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Neuroendocrine studies in affective disorders. Part 1. Plasma prolactin response to thyrotropin-releasing hormone in affective disorders: effect of ECT

12 August 2023

28

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Electroconvulsive therapy and the brain: evidence for increased dopamine-mediated responses.

12 August 2023

30

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Apomorphine hypothermia: an index of central dopamine receptor function in man

12 August 2023

31

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Human platelet α2-adrenergic receptors: Labeling with 3H-yohimbine, a selective antagonist ligand

12 August 2023

32

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Seizures down-regulate muscarinic cholinergic receptors in hippocampal formation.

12 August 2023

33

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Studies on possible mechanisms of action of electroconvulsive therapy; effects of repeated electrically induced seizures on rat brain receptors for monoamines and other neurotransmitters

12 August 2023

34

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin

12 August 2023

35

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Synaptic organization of the dopaminergic neurons in the rabbit retina

12 August 2023

36

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

β-Endorphin-Like Immunoreactivity in Cerebrospinal Fluid and Plasma of Patients with Schizophrenia and Other Neuropsychiatric Disorders

12 August 2023

38

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Effect of electroshock on dopamine metabolism in rat brain

12 August 2023

40

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Effect of electroshock on 5-HT metabolism in rat brain

12 August 2023

41

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs

12 August 2023

42

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Cholinergic aspects of convulsive therapy

12 August 2023

45

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Enhanced serotonin receptor activity after chronic treatment with imipramine or amitriptyline

12 August 2023

46

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Autonomic nervous system changes following electric shock treatment

12 August 2023

47

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Platelet alpha 2-adrenergic receptors in major depressive disorder. Binding of tritiated clonidine before and after tricyclic antidepressant drug treatment

12 August 2023

48

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Assessment of peripheral adrenergic activity and its interactions with drugs in man

12 August 2023

49

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Chronic electroconvulsive shock and chronic haloperidol administration are not additive in effects on dopamine receptors

12 August 2023

50

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

The TRH test in the diagnosis of major and minor depression

12 August 2023

51

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Dexamethasone suppression test as indicator of safe withdrawal of antidepressant therapy

12 August 2023

52

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Mechanism of the antidepressant action of electroconvulsive therapy

12 August 2023

53

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Normalization of dexamethasone suppression test: a laboratory index of recovery from endogenous depression

12 August 2023

54

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Further observations on the effect of repeated electroconvulsive shock on the behavioural resposes of rats produced by increases in the functional activity of brain 5-hydroxytryptamine and dopamine

12 August 2023

55

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Alterations in GABA metabolism and Met-enkephalin content in rat brain following repeated electroconvulsive shocks

12 August 2023

56

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Brain noradrenaline depletion prevents ECS-induced enhancement of serotonin- and dopamine-mediated behaviour

12 August 2023

58

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Enhanced 5-hydroxytryptamine and dopamine-mediated behavioural responses following convulsions—III the effects of monoamine antagonists and synthesis inhibitors on the ability of electroconvulsive shock to enhance responses

12 August 2023

59

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Repeated electroconvulsive shock increases the behavioural responses of rats to injection of both dopamine and dibutyryl cyclic amp into the nucleus accumbens

12 August 2023

60

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Studies on the locomotor activity produced by injection of dibutyryl cyclic 3 5 AMP into the nucleus accumbens of rats

12 August 2023

61

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Repeated electroconvulsive shock attenuates clonidine-induced hypoactivity in rodents.

12 August 2023

62

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Electroconvulsive shock: Sustained decrease in norepinephrine uptake affinity in a reserpine model of depression

12 August 2023

63

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

3HWB4101—Caution about its role as an alpha-adrenergic subtype selective radioligand

12 August 2023

65

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Opiate-like effects of electroconvulsive shock in rats: a differential effect of naloxone on nociceptive measures

12 August 2023

66

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Repeated electroconvulsive shocks and the brain content of endorphins

12 August 2023

68

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

beta-Endorphin immunoreactivity in the plasma of psychiatric patients receiving electroconvulsive treatment

12 August 2023

69

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Influence of chlorpromazine on the rabbit electroretinogram

12 August 2023

70

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Effects of apomorphine on the rabbit electroretinogram

12 August 2023

71

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

The Northwick Park electroconvulsive therapy trial.

12 August 2023

73

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Effects of naloxone-HCl on cortisol levels in patients with affective disorder and normal controls

12 August 2023

74

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Electroconvulsive Shock and Reserpine: Effects on ?-Adrenergic Receptors in Rat Brain

12 August 2023

77

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Differential effects of electroconvulsive shock and antidepressant drugs on serotonin-2 receptors in rat brain

12 August 2023

78

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Brain contribution to the haloperidol-induced increase in plasma homovanillic acid

12 August 2023

79

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

A sustained effect of electroconvulsive shock on the turnover of norepinephrine in the central nervous system of the rat

12 August 2023

80

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

TSH responses to TRH in endogenous depression

12 August 2023

81

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Effect of apomorphine on growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone levels in human serum

12 August 2023

82

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

A Controlled Comparison of Simulated and Real ECT

12 August 2023

83

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Reduced growth hormone responses to amphetamine in "endogenous" depressive patients: studies in normal, "reactive" and "endogenous" depressive, schizophrenic, and chronic alcoholic subjects

12 August 2023

85

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Dopaminergic factors in human prolactin regulation: A pituitary model for the study of a neuroendocrine system in man

12 August 2023

86

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Presynaptic regulation of catecholamine release

12 August 2023

87

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Effect of single and repeated electroconvulsive shock on serotonergic system in rat brain--II. Behavioural studies

12 August 2023

89

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Subsensitivity of human beta-adrenergic adenylate cyclase after salbutamol treatment of depression.

12 August 2023

90

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Electroconvulsive shock prevents dopamine receptor supersensitivity

12 August 2023

92

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Chronic treatment with antidepressant drugs: Potentiation of apomorphine-induced aggressive behaviour in rats

12 August 2023

97

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Effects of chronic administration of antidepressant drugs on aggressive behavior induced by clonidine in mice

12 August 2023

98

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Effect of pimozide on levodopa-induced growth hormone release in man

12 August 2023

99

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Effect of clonidine on growth hormone release in psychiatric patients and controls

12 August 2023

100

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Enhanced growth hormone response to clonidine after repeated electroconvulsive shock in a primate species

12 August 2023

101

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Amine Precursors and Depression

12 August 2023

102

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Suppression of sleep-related prolactin secretion and enhancement of sleep-related growth hormone secretion

12 August 2023

103

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

α1-adrenoceptor-mediated responses in the lateral geniculate nucleus are enhanced by chronic antidepressant treatment

12 August 2023

104

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Effect of electroconvulsive shock on the uptake and release of noradrenaline and 5-hydroxytryptamine in rat brain slices

12 August 2023

105

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Electroconvulsive shock and postsynaptic catecholamine effects: Increased psychomotor stimulant action of apomorphine and clonidine in reserpine pretreated mice by repeated ECS

12 August 2023

106

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Long-term effects of electroconvulsive shock therapy on synthesis, turnover and uptake of brain monoamines.

12 August 2023

108

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Electroconvulsive shock treatment decreases β-adrenergic receptor sensitivity in rat brain

12 August 2023

113

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Neuroendocrine measures in psychiatric patients: course and outcome with ECT

12 August 2023

114

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Depressed patients have decreased binding of tritiated imipramine to platelet serotonin "transporter".

12 August 2023

115

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Long-Term Antidepressant Treatment Decreases Spiroperidol-Labeled Serotonin Receptor Binding

12 August 2023

117

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Two distinct central serotonin receptors with different physiological functions

12 August 2023

118

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Depression by chronic electroconvulsive treatment of clonidine hypotherma and [3H]clonidine binding to rat cortical membranes.

12 August 2023

119

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

The systolic blood pressure response of depressed patients to infused norepinephrine

12 August 2023

120

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Adrenergic Blockade and the Corticosteroid and Growth Hormone Responses to Methylamphetamine

12 August 2023

121

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Growth hormone and prolactin in unipolar and bipolar depressed patients: responses to hypoglycemia and L-dopa

12 August 2023

123

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Dextroamphetamine and cortisol in depression. Morning plasma cortisol levels suppressed

12 August 2023

125

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Repeated electroconvulsive shock prevents the sedative effect of small doses of apomorphine

12 August 2023

127

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls

12 August 2023

130

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Experimental and clinical evidence of the antidepressant effect of a beta-adrenergic stimulant

12 August 2023

131

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

A neuroendocrine study of the mechanism of action of ECT

12 August 2023

133

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Prognostic value of adrenaline and mecholyl responses in electroconvulsive therapy. II

12 August 2023

134

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Comparison of the effects of repeated electroconvulsive shock on alpha 2- and beta-adrenoceptors in different regions of rat brain

12 August 2023

135

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Tritiated imipramine binding sites are decreased in the frontal cortex of suicides.

12 August 2023

136

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Increased serotonin-2 binding sites in frontal cortex of suicide victims

12 August 2023

137

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Interaction of desipramine and amitriptyline with adrenergic mechanisms in the human iris in vivo

12 August 2023

139

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

5-Hydroxyindoleacetic Acid Levels in the Cerebrospinal Fluid of Depressive Patients treated with Probenecid

12 August 2023

142

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Central serotonin metabolism and frequency of depression

12 August 2023

143

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain

12 August 2023

144

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Enhancement of responsiveness of the central serotonergic system and serotonin-2 receptor density in rat frontal cortex by electroconvulsive treatment.

12 August 2023

145

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Increased sensitivity to dopaminergic agonists after repeated electroconvulsive shock (ECS) in rats

12 August 2023

147

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Prolactin response following intravenous and oral sulpiride in healthy human subjects in relation to sulpiride concentrations

12 August 2023

148

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Monoamine Oxidase and Free Tryptophan in Human Plasma: Normal Variations and Their Implications for Biochemical Research in Affective Disorders

12 August 2023

149

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

Pupil size and spontaneous pupillary waves associated with alertness, drowsiness, and sleep

12 August 2023

150

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90120-3

12 August 2023

Identifiers

1 reference

16 February 2018

1 reference

16 February 2018